#USA #New York #AI Healthcare #Nabla #Dr. Matt Sakumoto

Nabla Strengthens Clinical Strategy with New Appointment

Nabla, a leading AI assistant in clinical care, is making significant strides in its growth journey by announcing the appointment of Dr. Matt Sakumoto as its Chief Clinical Product Officer. This strategic move aims to bolster the integration of real-world clinical experience into Nabla’s product development, particularly as the organization strives to expand its clinician-led initiatives in the rapidly evolving healthcare landscape.

Dr. Sakumoto, known for his expertise in clinical informatics and hands-on experience as a physician, steps into this pivotal role at a time when Nabla is poised to refine its product offerings, ensuring they are clinically sound, intuitive, and essential across various clinical workflows. His role is crucial in maintaining the integrity of the AI assistant as it scales, allowing for a deeper integration of the clinician's perspective in decision-making processes.

In her remarks about this appointment, Delphine Groll, Co-Founder and COO of Nabla, stressed the importance of aligning product development with frontline clinical practice. She stated, "As Nabla moves into its next phase of product maturity, where clinical context and workflow nuance matter as much as speed, we need to continue anchoring product decisions in frontline clinical practice." Dr. Sakumoto’s background in delivering care and leading clinical informatics initiatives positions him as an ideal leader for this next chapter in Nabla's journey.

The addition of Dr. Sakumoto to Nabla’s executive team signifies the ongoing evolution and depth of clinical leadership within the company. With established roles for both a Chief Medical Officer and now a Chief Clinical Product Officer, Nabla emphasizes its belief that effective healthcare AI solutions must be developed by clinicians for clinicians, ensuring a product that resonates deeply with the needs of healthcare workers and patients alike.

What sets Dr. Sakumoto apart is not only his impressive track record at organizations such as Sutter Health and UCSF but also his commitment to enhancing patient care through innovative AI tools. In his own words, he expressed enthusiasm about joining Nabla, stating, "What excites me most about Nabla is the team’s commitment to partnering with clinicians and reimagining clinical workflows in an AI-enabled environment." He recognizes a prevalent issue in the current landscape where numerous AI tools fail to adequately support real-world medical practices, and he is keen to contribute to Nabla’s mission to bridge that gap.

Dr. Sakumoto’s leadership experience in clinical informatics, virtual care delivery, and AI integration in regulated health systems positions him uniquely to guide Nabla’s direction. His involvement extends beyond direct leadership roles; he is also engaged with influential organizations such as the American College of Physicians and the Coalition for Health AI, where he shapes discussions on policy, standards, and best practices in healthcare AI.

As Nabla continues to evolve, its mission remains clear: to restore the human connection at the heart of healthcare through groundbreaking clinical AI solutions that simplify workflows and improve patient outcomes. The AI assistant is designed to assist clinicians in generating notes with unprecedented speed and accuracy through innovative technologies like ambient documentation.

With Dr. Sakumoto onboard, Nabla is intensifying its efforts to expand its suite of products and services that adapt to the diverse needs of clinical workflows and settings. The company's ability to integrate seamlessly with major Electronic Health Record (EHR) systems and its support for multiple languages demonstrate its commitment to inclusivity and adaptability.

Looking ahead, Nabla’s vision is to create an adaptive platform that supports a wider array of workflows, enhancing the clinician's ability to focus on what truly matters: patient care. The appointment of Dr. Sakumoto is a testament to Nabla’s strategy of embedding clinical expertise within its framework, promising a future where AI technology works hand-in-hand with healthcare professionals to enrich the care experience for patients and providers alike.

As Nabla takes these exciting steps forward in innovation and leadership, it reinforces its commitment to changing the way healthcare is delivered, marking a new era in clinical AI that promotes efficiency without sacrificing the essential human touch in medicine.